Zyprexa VELOTAB. 15 mg. 28 tablets
Schizophrenia - a disease with symptoms such as hearing, seeing or sensing things, mistaken beliefs, unusual suspiciousness, isolation (withdrawal). People with this disease may also feel depressed, anxious or tense.
Zyprexa VELOTAB. 15 mg. 28 tablets
What is ZYPREXA VELOTAB and what it is used
ZYPREXA VELOTAB belongs to the group of medicines called antipsychotics and is used for treatment of the following diseases:
Schizophrenia - a disease with symptoms such as hearing , seeing or sensing things , mistaken beliefs , unusual suspiciousness , isolation ( withdrawal ) . People with this disease may also feel depressed, anxious or tense ;
Moderate to severe manic episodes - a condition with symptoms of excitement or euphoria.
ZYPREXA VELOTAB shows that prevents recurrence of these symptoms patsenti with bipolar disorder where manic episode has responded to treatment with olanzapine.
2 . What you should know before taking ZYPREXA VELOTAB
Do not take ZYPREXA VELOTAB
If you are allergic (hypersensitive) to olanzapine or any of the other ingredients of this medicine (listed in Section 6). An allergic reaction may be recognized as a rash , itching, swollen face, swollen lips or shortness of breath . If this happens to you, talk to your doctor ;
If you have been diagnosed with eye problems such as certain forms of glaucoma (increased pressure in the eye) .
Warnings and Precautions
Talk to your doctor or pharmacist before taking ZYPREXA VELOTAB:
Not recommended for use ZYPREXA VELOTAB in elderly patients with dementia as they this medication can have serious side effects ;
Drugs of this type may cause unusual movements mainly of the face and tongue. If this happens after you take ZYPREXA VELOTAB, tell your doctor ;
Very rarely , medicines of this type cause a combination of fever, faster breathing , sweating, muscle stiffness and drowsiness or sleepiness . If this happens , contact your doctor immediately ;
There was weight gain in patients taking ZYPREXA VELOTAB. You and your doctor should regularly check your weight ;
In patients taking ZYPREXA VELOTAB, observed high levels of blood sugar and blood fat (triglycerides and cholesterol) . Your doctor should do blood tests to check blood sugar levels and some fat before you start taking ZYPREXA VELOTAB and regularly during treatment ;
Tell your doctor if you or anyone in your family ever had blood clots, as medicines like it have been associated with formation of blood clots.
If you suffer from any of the following illnesses tell your doctor as soon as possible:
Stroke or " mini " stroke (temporary symptoms of stroke) ;
Prostate problems ;
Intestinal obstruction ( paralytic ileus ) ;
Liver or kidney disease ;
Blood disorders ;
Heart disease ;
If you suffer from dementia, you or the person who takes care of you / your relative should tell your doctor if you have ever had a stroke or " mini " stroke .
As a routine precaution, if you are aged over 65 , your blood pressure should be monitored by your doctor.
Children and adolescents
ZYPREXA VELOTAB is not intended for people under 18 years of age.
Other medicines, ZYPREXA VELOTAB
Take other medicines during treatment with ZYPREXA VELOTAB, if your doctor has told you that this is possible . You might feel drowsy if you take ZYPREXA VELOTAB in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillizers ) .
Tell your doctor if you are taking , have recently taken or taking other medicines.
In particular, tell your doctor if you take:
medications for Parkinson's disease;
carbamazepine ( antiepileptic and mood stabilizing drug) , fluvoxamine ( an antidepressant ) , or ciprofloxacin (an antibiotic) , as it may need to change your dose of ZYPREXA VELOTAB.
ZYPREXA VELOTAB alcohol
Do not drink alcohol during treatment with ZYPREXA VELOTAB, since simultaneously with alcohol can cause drowsiness .
Pregnancy and lactation
If you are pregnant or breast-feeding, you may be pregnant or planning to become pregnant , talk to your doctor before taking this medicine.
You should not take this medicine when breast-feeding , as small amounts of ZYPREXA VELOTAB can pass into breast milk.
The following symptoms may occur in newborns whose mothers have used ZYPREXA VELOTAB in the last trimester ( last three months of pregnancy ): shaking, numbness and / or muscle weakness , somnolence , agitation, trouble breathing and feeding difficulty . If your baby develops any of these symptoms , seek your doctor
Driving and using machines
There is a risk of feeling drowsy while taking ZYPREXA VELOTAB. If this happens do not drive or operate any tools or machines. Tell your doctor.
ZYPREXA VELOTAB contains aspartame , mannitol and sodium and sodium methylparahydroxybenzoate propylparahydroxybenzoate .
Patients who can not take phenylalanine should know that ZYPREXA VELOTAB contains aspartame , a source of phenylalanine. It can be harmful for people with phenylketonuria.
Patients who can not receive mannitol should know that ZYPREXA VELOTAB contains mannitol.
ZYPREXA VELOTAB contains sodium and sodium methylparahydroxybenzoate propylparahydroxybenzoate that may cause an allergic reaction in some people. An allergic reaction may be detected by the appearance of a rash , itching or shortness of breath . This can occur immediately or some time after you take ZYPREXA VELOTAB.
3 . How to take ZYPREXA VELOTAB
Always take this medicine exactly as your doctor tells you . If you are not sure, ask your doctor or pharmacist.
Your doctor will tell you how many tablets ZYPREXA VELOTAB to take and how long to take them . The daily dose of ZYPREXA VELOTAB is between 5 and 20 mg. Consult your doctor if your symptoms return but do not stop taking ZYPREXA VELOTAB, unless your doctor advises you to do so.
You should take ZYPREXA VELOTAB once a day following the advice of your doctor. Try to take your tablets at the same time each day . Taking the tablets is independent of food intake. ZYPREXA VELOTAB, tablets orodispersible is for oral use .
ZYPREXA VELOTAB tablets break easily , so you have to handle them very carefully. Do not handle the tablets with wet hands as they may break .
1. Hold the blister strip at the edges and separate one blister cell from the rest strip by gently tearing off along the perforated line.
2 . Carefully open the box by removing the lid foil .
3 . Gently push the tablet.
4 . Place the tablet in your mouth . It will dissolve directly in your mouth and you will be able to swallow easily.
You can also place the tablet in a glass of water or orange juice, apple juice, milk or coffee and stir . In some beverages , the mixing of the tablet can result in discoloration or clouding of the liquid. Drink immediately.
If you take more dose ZYPREXA VELOTAB
Patients who received more than the required amount ZYPREXA VELOTAB experienced the following symptoms: fast heart rate , agitation / aggressiveness, problems with speech , unusual movements ( especially of the face or tongue) and reduced level of consciousness. Other symptoms may be: acute confusion, seizures (epilepsy ) , coma , a combination of fever, faster breathing, sweating , muscle stiffness and drowsiness or sleepiness, slow heart rate , aspiration, high or low blood pressure, irregular heart rhythm. Contact your doctor or just go to the nearest hospital if you have any of the above symptoms. Show the doctor your pack of tablets.
If you forget to take ZYPREXA VELOTAB
Take your tablets as soon as you remember . Do not take two doses in one day.
If you stop taking ZYPREXA VELOTAB
Do not stop taking your tablets just because you feel better. It is important to keep taking ZYPREXA VELOTAB as long as your doctor tells you .
If you suddenly stop taking ZYPREXA VELOTAB, may experience symptoms such as sweating , insomnia, tremor, anxiety or nausea and vomiting. Your doctor may advise you to reduce the dose gradually before stopping treatment.
If you have any questions about using this medicine, ask your doctor or pharmacist.
4 . Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor if you have:
unusual movements (a common side effect that may affect up to 1 in 10 people) mainly of the face or tongue ;
blood clots in the veins ( an uncommon side effect that may affect up to 1 in 100 people ), especially in the legs ( symptoms include swelling , pain and redness in the leg), which may travel through blood vessels to the lungs causing pain chest and difficulty breathing. If you notice any of these symptoms , seek medical advice immediately;
combination of fever, faster breathing, sweating , muscle stiffness and drowsiness or somnolence (frequency of this side effect can not be estimated from available data).
Very common side effects (may affect more than 1 in 10 people ) include weight gain, drowsiness and increases in prolactin levels in the blood. At the beginning of treatment , some people may feel dizzy or faint (with a slow heart rate ), especially when getting up from a lying or sitting position. This usually resolves by itself , but if it does not, tell your doctor.
Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells and circulating fats early in treatment transient increases in liver enzymes , increased levels of sugar in blood and urine , increased levels of uric acid and blood creatine phosphokinase , increased hunger , dizziness , anxiety , tremors , abnormal movements ( dyskinesias ), constipation , dry mouth , rash , loss of strength , extreme tiredness , water retention leading to swelling of the hands , ankles or the steps , high temperature, joint pain and sexual dysfunction , such as decreased libido in both men and women or in male erectile dysfunction .
Uncommon side effects (may affect up to 1 in 100 people ) include hypersensitivity reactions (eg , swelling of the mouth and throat, itching, rash ), diabetes or worsening of diabetes occasionally associated with ketoacidosis (ketones in the blood and urine) or coma ; seizures , usually associated with seizures in the past ( epilepsy) muscle stiffness or spasm (including eye movements ), speech problems , slow heartbeat , sensitivity to sunlight , nosebleeds , bloating , loss of memory or forgetfulness ; urinary incontinence , difficulty in passing urine , hair, loss or reduction of menstrual cycles and breast changes in males and females such as an abnormal production of breast milk or abnormal growth .
Rare side effects (may affect up to 1 in 1000 people) include lowering of normal body temperature, heart rhythm disorders , sudden unexplained death, inflammation of the pancreas causing severe stomach pain, fever and malaise ; liver disease appearing as yellowing skin and whites of the eyes , muscle disease presenting as unexplained aches and pains and prolonged and / or painful erection .
While taking olanzapine , elderly patients with dementia may suffer from stroke , pneumonia, urinary incontinence, falls, extreme tiredness, visual hallucinations, a rise in body temperature, redness of the skin and have trouble walking . In this particular group of patients has been reported for several fatalities .
In patients with Parkinson's disease , ZYPREXA VELOTAB can lead to worsening of symptoms .
If you get any side effects tell your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
5 . How to store ZYPREXA VELOTAB
Keep out of reach of children.
Do not use this medicine after the expiry date stated on the carton .
ZYPREXA VELOTAB should not store in the original package to protect from light and moisture.
Do not dispose of medications in wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required . These measures will spomognot for environmental protection .
6 . Package Contents and more information
What does ZYPREXA VELOTAB
The active ingredient is olanzapine . Each orodispersible tablet ZYPREXA VELOTAB comprises 5 mg, 10 mg, 15 mg or 20 mg of active substance . The exact amount is shown on the packaging of your ZYPREXA VELOTAB.
The other ingredients are gelatin , mannitol (E421), aspartame (E951), sodium methyl para-hydroxybenzoate (E219) and sodium propylparahydroxybenzoate (E217).
ZYPREXA VELOTAB looks like and contents of the pack
ZYPREXA VELOTAB 5 mg, 10 mg, 15 mg and 20 mg tablets are yellow , orodispersible . Orodispersible tablet in the mouth is the technical name of a tablet , which is dissolved directly in the mouth so that it can be easily swallowed .
ZYPREXA VELOTAB is available in cartons containing 28, 35 , 56, 70 or 98 tablets.
Not all pack sizes may be marketed.